Our MRS testing method enables non-invasive tests of glucose and other metabolites by scanning a finger. U.S. Patent No. 11,237,237.
Novel spectrometer and probe designs achieve extremely low noise for optimal measurement sensitivity yielding fast and accurate tests for point-of-care medicine. photo credit
Our proprietary RF excitation pulse sequence and DFT based resonance signal processing specific to glucose represents a major advance for accurate MRS testing.
Patent pending gradient shimming technology achieves excellent magnetic field uniformity and spectral resolution for biomarker test specificity.
Our patent pending magnet array design improves field strength to volume/weight relative to traditional Halbach arrays enabling a portable and more ergonomic form factor.
Spatially uniform high power circularly polarized RF excitation and high sensitivity I/Q signal reception with a probe designed for in vivo measurements.
We provide measurement results you can count on.
Magnetic Resonance Spectroscopy (MRS) provides quantitation of many metabolites used as biomarkers in clinical medicine.
MRS research has detected over 40 metabolites in vitro and up to 15 in vivo.
Attest's team has decades of experience designing chip test equipment for 24/7 operation in factories around the world.
Our networked test solutions support telehealth to improve patient access and clinical decision making.
We are developing a portable, accurate, and convenient to use device for testing biomarkers used in the screening, diagnosis, and management of metabolic conditions like diabetes. For many people with or at risk for diabetes the required glucose test frequency is too high to be acceptable with finger prick testing but not high enough to justify a continuous glucose monitor (CGM). Using our non-invasive devices to conduct more frequent spot-testing for screening and optimal condition management enables lifestyle interventions shown to prevent diabetes in 6 of 10 people with pre-diabetes.Read More
If you are interested in learning more about ATTEST please get in touch.